Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer

Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA

PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer ( Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA )

Results from the PALOMA-3 trial for advanced breast cancer

Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA

Results from the PALOMA-3 trial for advanced breast cancer ( Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA )

Societal indicators of lung cancer screening behaviours

Prof Jean-François Morère - Hôpital Paul Brousse, Villejuif, France

Societal indicators of lung cancer screening behaviours ( Prof Jean-François Morère - Hôpital Paul Brousse, Villejuif, France )

Rare EGFR mutations in lung adenocarcinoma

Prof Nicolas Girard - Institut Curie, Paris, France

Rare EGFR mutations in lung adenocarcinoma ( Prof Nicolas Girard - Institut Curie, Paris, France )

Magnetic marker to judge pathological response to checkpoint therapy in melanoma

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

Magnetic marker to judge pathological response to checkpoint therapy in melanoma ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )

New therapeutic options in advanced and metastatic breast cancer

Dr Fatima Cardoso - Champalimaud Clinical Center, Lisbon, Portugal

New therapeutic options in advanced and metastatic breast cancer ( Dr Fatima Cardoso - Champalimaud Clinical Center, Lisbon, Portugal )

Immunological monitoring of patients receiving immunotherapy

Prof Jaques van Dongen - Leiden University, Netherlands

Immunological monitoring of patients receiving immunotherapy ( Prof Jaques van Dongen - Leiden University, Netherlands )

Novel therapies for paediatric B-ALL

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Novel therapies for paediatric B-ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Can we reduce the intensity of frontline therapy?

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Can we reduce the intensity of frontline therapy? ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Latest concepts in the diagnosis of genetic ALL subtypes

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA

Latest concepts in the diagnosis of genetic ALL subtypes ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )

In vitro diagnostic models for ALL: what can we learn on actionable targets?

Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland

In vitro diagnostic models for ALL: what can we learn on actionable targets? ( Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland )

For HSCT in Ph-positive ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK

For HSCT in Ph-positive ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )

More from ecancer